Tracking lipid droplet dynamics for in vivo visualization of breast cancer models by a BODIPY-based fluorescent probe.
Abstract
Breast cancer, a major malignancy with a complex tissue structure, poses significant challenges for early diagnosis and effective treatment due to the difficulty in detecting microscopic lesions. Lipid metabolic reprogramming in tumor cells, characterized by enhanced lipid uptake and lipid droplet (LD) accumulation, plays a crucial role in cancer progression, highlighting the importance of real-time imaging of LDs for precise cancer diagnosis. Various LDs imaging probes have been reported, but their poor water solubility and suboptimal spectral properties limit their application in vivo. In this study, we present a novel fluorescent probe, LysBODIPY, for the specific visualization of LDs in tumor cells and in vivo. LysBODIPY demonstrates selective accumulation in LDs, as confirmed by colocalization experiments, enabling high-contrast intracellular imaging and effective discrimination between normal and cancerous cells. Furthermore, LysBODIPY enables fluorescence imaging of the tumor region in a murine breast cancer model by intratumoral administration, demonstrating its feasibility for localized tumor fluorescence imaging. Overall, LysBODIPY offers a reliable tool for monitoring LD dynamics in tumor cells and provides a useful platform for investigating lipid metabolism in cancer biology.